World-first immunizations providing protection against deadly respiratory syncytial virus (RSV) could be just months away thanks to global research efforts spanning multiple decades.
Aug 23, 2022
0
173
A smartphone app could enable greater participation in clinical trials for people with frontotemporal dementia (FTD), a devastating neurological disorder that often manifests in midlife.
Apr 1, 2024
0
36
3D eye scans can reveal vital clues about kidney health that could help to track the progression of disease, research suggests. The advance could revolutionize the monitoring of kidney disease, which often progresses without ...
Dec 5, 2023
0
83
Prostate cancers remain localized in the majority of cases, giving affected individuals a good chance of survival. However, about 20% of patients develop incurable metastatic prostate cancer, resulting in approximately 5,000 ...
Apr 4, 2022
0
9
A combination of drugs will be needed to effectively treat or prevent Alzheimer's disease and leading experts say we have entered a new era of drug development that will deliver them. In an editorial published in the Journal ...
Jul 6, 2022
0
21
A new biologic "patch" that is activated by a person's natural motion could be the key to fixing herniated disks in people's backs, according to researchers at the Perelman School of Medicine at the University of Pennsylvania ...
Nov 15, 2023
0
102
Sarcopenia is the progressive and accelerated loss of muscle mass and strength as we age.
May 17, 2023
0
34
A large retrospective study conducted by physician researchers from Roswell Park Comprehensive Cancer Center reports benefits of chemotherapy for many patients with early-stage breast cancer with rare variant histology, or ...
Apr 18, 2023
0
2
Alzheimer's is a debilitating neurodegenerative and neuroinflammatory disease that is difficult to treat. Most existing therapies target the buildup of amyloid beta (Aβ) plaques in the brain, which requires early intervention ...
Sep 14, 2023
0
211
A University of Cincinnati clinical trial that added an immunotherapy drug to standard of care treatment regimens has shown increased survival rates for head and neck cancer patients with intermediate risk features.
Mar 1, 2022
0
39
